ClinicalTrials.Veeva

Menu

Choice of Palliative Procedures for Pulmonary Atresia With Ventricular Septal Defect Patients

M

Meshalkin Research Institute of Pathology of Circulation

Status

Completed

Conditions

Tetralogy of Fallot With Pulmonary Atresia
Pulmonary Atresia With Ventricular Septal Defect

Treatments

Procedure: Systemic-to-pulmonary artery shunts
Procedure: Experimental: RVOT reconstruction by femoral allogenic vein valve conduit

Study type

Interventional

Funder types

NETWORK

Identifiers

Details and patient eligibility

About

The aim is to compare effective growth true hypoplastic pulmonary arteries using Right Ventricle Outflow Tract Reconstruction by femoral allogenic vein valve conduit and systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)

Full description

The use of femoral allogenic vein valve conduit for Right Ventricle Outflow Tract Reconstruction is good alternative systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt). Main advantages is straight, symmetrical, pulsating, systolic blood flow in hypoplastic pulmonary artery, which stimulate growth and prepares for a radical repair. Taking into account the absence randomized studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual.

Enrollment

24 patients

Sex

All

Ages

1 day to 1 year old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

Patients who met the following criteria were included:

  • Patients with PA-VSD type A and B (by Tchervenkov) scheduled for palliative surgery
  • Age less than one year
  • Confluent pulmonary artery
  • Nakata Index ≤ 120 mm2/m2. Exclusion criteria

Patients who met any of the following criteria were excluded:

  • Discordant atrioventricular and/or discordant ventriculo-arterial connections
  • Concomitant pathology (pneumonia, brain damage, or enterocolitis)
  • Genetic syndromes (DiGeorge, Alagille, VACTER, CHARGE)
  • Scheduled MAPCA unifocalisation
  • Anomalous coronary arteries
  • Other surgical approaches (complete primary repair, primary unification of pulmonary blood flow, stenting RVOT, or patent ductus arteriosus, radiofrequency pulmonary valve perforation).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Right ventricle outflow tract reconstruction
Experimental group
Description:
RVOT reconstruction used femoral allogenic vein valve conduit through ventricular fibrillation and without VSD closure
Treatment:
Procedure: Experimental: RVOT reconstruction by femoral allogenic vein valve conduit
Systemic-to-pulmonary artery shunts
Active Comparator group
Description:
systemic-to-pulmonary artery shunts (modified Blalock-Taussig shunt)
Treatment:
Procedure: Systemic-to-pulmonary artery shunts

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems